#136 How Did Diabetes Medications Become Obesity Meds? Beyond Journal Club on SURMOUNT-1 Trial

<p>What is the difference between semaglutide (ozempic) and tirzepatide (mounjaro) in outcomes and mechanism? How did we find out diabetes medications can help with weight loss?</p><p>Sponsors: <a href="https://www.coreimpodcast.com/post" rel="nofollow">Post Investment: Real Estate Syndications</a> || <a href="https://www.coreimpodcast.com/hellofresh" rel="nofollow">Hellofresh</a>  </p><p><a href="https://www.coreimpodcast.com/2023/10/04/bjc-episode-2-surmount-1-trial/" rel="nofollow">Show Notes &amp; Transcript</a></p><ul><li>02:08 Framework for thinking about obesity</li><li>03:42 History of obesity treatment</li><li>06:29 Gila monsters and GLP and GIP mechanisms</li><li>08:29 Story of how medications for diabetes were found to have a weight loss benefit</li><li>12:50 SURMOUNT-1 trial</li></ul><p><br></p><p>Tags: IMCore, CoreIM, primary care, cardiology, nurse practitioner, pharmacist, physician assistant</p><br /><br />Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840<br/><br/>Advertising Inquiries: <a href='https://redcircle.com/brands'>https://redcircle.com/brands</a><br/><br/>Privacy & Opt-Out: <a href='https://redcircle.com/privacy'>https://redcircle.com/privacy</a>